Explore

Trendline Trendline
Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status

Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status

Akari Therapeutics Reports Increased Net Loss in Q1 2026 Amid Pre-Revenue Status
Trendline Trendline
CEL-SCI Reports Progress in Multikine Development and Financial Results

CEL-SCI Reports Progress in Multikine Development and Financial Results

CEL-SCI Reports Progress in Multikine Development and Financial Results
Trendline Trendline
Evofem Biosciences Reports Q1 2026 Financial Results Amid Strategic Expansion

Evofem Biosciences Reports Q1 2026 Financial Results Amid Strategic Expansion

Evofem Biosciences Reports Q1 2026 Financial Results Amid Strategic Expansion
Trendline Trendline
Parabilis Biotech Files for IPO to Fund Cancer Drug Trials

Parabilis Biotech Files for IPO to Fund Cancer Drug Trials

Parabilis Biotech Files for IPO to Fund Cancer Drug Trials
Trendline Trendline
IGC Pharma Advances Alzheimer's Trial, Reports Financial Results

IGC Pharma Advances Alzheimer's Trial, Reports Financial Results

IGC Pharma Advances Alzheimer's Trial, Reports Financial Results
Trendline Trendline
Evogene Announces Q1 2026 Financial Results Highlighting Strategic Collaborations and Financial Adjustments

Evogene Announces Q1 2026 Financial Results Highlighting Strategic Collaborations and Financial Adjustments

Evogene Announces Q1 2026 Financial Results Highlighting Strategic Collaborations and Financial Adjustments
Trendline Trendline
Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform
Trendline Trendline
Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate

Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate

Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate
Trendline Trendline
Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development

Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development

Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development
Trendline Trendline
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Trendline Trendline
Inmune Bio to Release Year-End 2025 Financial Results, Impacting Investor Sentiment

Inmune Bio to Release Year-End 2025 Financial Results, Impacting Investor Sentiment

Inmune Bio to Release Year-End 2025 Financial Results, Impacting Investor Sentiment
Trendline Trendline
Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations

Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations

Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations